[HTML][HTML] Success of checkpoint blockade paves the way for novel immune therapy in malignant pleural mesothelioma
L Rondon, R Fu, MR Patel - Cancers, 2023 - mdpi.com
Simple Summary This review article will focus on the landmark studies that came to define
current treatment paradigms for malignant pleural mesothelioma (MPM), all the way from …
current treatment paradigms for malignant pleural mesothelioma (MPM), all the way from …
[HTML][HTML] The evolving role of immune-checkpoint inhibitors in Malignant pleural mesothelioma
M Borgeaud, F Kim, A Friedlaender, F Lococo… - Journal of Clinical …, 2023 - mdpi.com
Malignant pleural mesothelioma (MPM) is a rare cancer usually caused by asbestos
exposure and associated with a very poor prognosis. After more than a decade without new …
exposure and associated with a very poor prognosis. After more than a decade without new …
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies
E Andrini, AD Federico, M Sisi, M Rosellini… - …, 2022 - Future Medicine
In recent years, immunotherapy has significantly changed the treatment of locally
advanced/metastatic non-small-cell lung cancer (NSCLC). Conversely, the role of …
advanced/metastatic non-small-cell lung cancer (NSCLC). Conversely, the role of …